Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Rating of “Hold” from Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have received an average recommendation of “Hold” from the four brokerages that are presently covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $10.30.

Several research firms have recently commented on MD. TheStreet lowered shares of Pediatrix Medical Group from a “c” rating to a “d” rating in a research note on Friday, February 23rd. Truist Financial cut their target price on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating on the stock in a research note on Wednesday, February 21st. Jefferies Financial Group decreased their price target on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, March 6th. Finally, Mizuho decreased their price objective on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a report on Wednesday, February 21st.

Institutional Investors Weigh In On Pediatrix Medical Group

Large investors have recently modified their holdings of the stock. Performa Ltd US LLC grew its holdings in Pediatrix Medical Group by 130.8% in the fourth quarter. Performa Ltd US LLC now owns 3,000 shares of the company’s stock valued at $28,000 after purchasing an additional 1,700 shares during the last quarter. Counterpoint Mutual Funds LLC purchased a new position in shares of Pediatrix Medical Group during the 3rd quarter worth about $84,000. Equita Financial Network Inc. acquired a new stake in shares of Pediatrix Medical Group during the 3rd quarter worth $128,000. AXQ Capital LP acquired a new stake in Pediatrix Medical Group during the third quarter worth about $135,000. Finally, Jump Financial LLC purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter worth about $154,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Down 0.2 %

Shares of MD stock opened at $9.02 on Thursday. The company has a 50-day moving average of $9.20 and a two-hundred day moving average of $9.56. The firm has a market cap of $757.95 million, a PE ratio of -12.36, a price-to-earnings-growth ratio of 2.44 and a beta of 1.58. Pediatrix Medical Group has a 1-year low of $7.70 and a 1-year high of $15.06. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.24 and a quick ratio of 1.24.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. The firm had revenue of $496.44 million during the quarter, compared to analysts’ expectations of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. The firm’s quarterly revenue was down 3.4% on a year-over-year basis. During the same quarter last year, the company posted $0.46 EPS. On average, analysts predict that Pediatrix Medical Group will post 1.12 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.